Revolutionizing Oncology Trials with End-to-End Digital Workflows and Intelligent Review Automation.

Built to navigate the intricate process of cancer research, this company enhances clinical trials by providing a smarter IRB experience tailored for sponsors, CROs, and research sites. It employs modern, proprietary technology to deliver end-to-end digital workflows free from legacy systems, ensuring predictable and transparent reviews faster than traditional methods. The firm specializes in oncology, leveraging over 144 years of combined experience to offer informed reviews that accommodate complex study designs, frequent amendments, and evolving safety information throughout multi-site trials.

The company distinguishes itself through technology-first workflows, including fully electronic submissions, intelligent review support, and a secure study dashboard for stakeholders. Their system rigorously checks for inconsistencies through automated pre-review processes, facilitating prompt and consistent decision-making. With expert reviewers and highly responsive regulatory specialists, they ensure structured protocol and consent oversight. They also manage single IRB models, ensuring seamless coordination across institutions, supported by a HIPAA-ready infrastructure that includes complete audit logs and role-based access control.